Quick Answer
Neuronetics, Inc. reported Cash and Equivalents of $28.13 million for fiscal year 2025.
Neuronetics, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $28.13M | +52.4% |
| 2024 | $18.46M | -69.1% |
| 2023 | $59.68M | -15.2% |
| 2022 | $70.34M | -25.3% |
| 2021 | $94.14M | +92.3% |
| 2020 | $48.96M | -35.3% |
| 2019 | $75.71M | -27.6% |
| 2018 | $104.58M | +258.8% |
| 2017 | $29.15M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $27.97M | +34.0% | +155.0% |
| June 30, 2025 | $10.97M | -74.3% | -45.8% |
| March 31, 2025 | $20.22M | -57.6% | +9.6% |
| December 31, 2024 | $18.46M | -69.1% | -11.5% |
| September 30, 2024 | $20.87M | -41.8% | -51.1% |
| June 30, 2024 | $42.64M | -7.1% | -10.7% |
| March 31, 2024 | $47.73M | -13.9% | -20.0% |
| December 31, 2023 | $59.68M | -15.2% | +66.5% |
- Neuronetics, Inc. showed an increase of +52.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2017–2025 period, Neuronetics, Inc.’s cash and equivalents has declined by 3.5% (from $29.15 million to $28.13 million).
- The most recent figure is from Neuronetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: